Injectable MPL allergy vaccine - Allergy Therapeutics

Drug Profile

Injectable MPL allergy vaccine - Allergy Therapeutics

Alternative Names: Birch pollen allergen extract; Birch pollen modified allergen tyrosine-absorbed; Grass MATA MPL; Grass pollen modified allergen tyrosine-adsorbed; Pollinex Quattro; Pollinex Quattro Grass; Pollinex Quattro Ragweed; Pollinex Quattro Tree; Pollinex Quattro® Birch; PQ Birch; PQ Grass; Ragweed MATA MPL - Allergy-Therapeutics; Tree MATA MPL

Latest Information Update: 17 Sep 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Allergy Therapeutics
  • Class Allergy immunotherapies; Antiallergics
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Grass pollen hypersensitivity
  • Phase III Allergic rhinoconjunctivitis; Ragweed pollen hypersensitivity
  • Phase II Seasonal allergic rhinitis; Tree pollen hypersensitivity

Most Recent Events

  • 20 Jun 2018 Allergy Therapeutics completes a phase III trial in Allergic rhinoconjunctivitis (Prevention) in Sweden, Germany, Poland and Austria (SC) (EudraCT2016-002781-31)
  • 21 May 2018 Efficacy data from a phase II trial in Allergic rhinoconjunctivitis released by Allergy Therapeutics
  • 21 May 2018 Allergy Therapeutics plans a phase III trial for Allergic disorders in 2019
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top